Will Humana's FY2026 adjusted EPS exceed the $9 guidance floor?
Current Prediction
Why This Question Matters
The $9 EPS guidance floor tests the Myth Meter's finding that management guidance contains 'higher than typical conservatism.' In FY2025, initial guidance was exceeded ($16.25 to $17.14). Beating $9 would narrow the NARRATIVE_REALITY_GAP by validating that management was sandbagging. Missing the $9 floor would represent a catastrophic credibility failure and signal deeper structural problems than acknowledged.
Prediction Distribution
Individual Predictions(9 runs)
CFO Mellet explicitly stated the $9 guidance contains 'higher than typical conservatism' with a 'broad haircut' on assumptions. In FY2025, management's initial guide of $16.25 was exceeded at $17.14 despite $550M+ in accelerated investments. Management clearly has a pattern of conservative initial guidance. The $9 floor is 'at least $9' — the 'at least' language is important, signaling a floor rather than a midpoint. The biggest risk is that the $3.5B Stars headwind creates genuinely unprecedented uncertainty and the conservatism is warranted. But even with the massive headwind, management's track record and explicit conservatism language suggest the floor is beatable.
The key analytical framework: Management guided FY2025 at $16.25, invested $550M+ into the business, and still delivered $17.14 — a $0.89 beat on top of the incremental spend. For FY2026, the $3.5B Stars headwind is a known quantity that management has had months to plan for. The 'broad haircut' on assumptions likely includes buffers for medical cost trends, new member economics, and rate notice outcomes. The question is how wide the buffer is. If management applied similar conservatism to FY2026 as FY2025, the actual could be $10-11. However, the scale of the Stars headwind creates more genuine downside scenarios than FY2025's relatively benign environment. Solid probability above coin-flip.
Two scenarios to consider: (1) The 'broad haircut' means management has 10-15% cushion above $9, putting real EPS at $10-10.5 — probability very high that $9 is exceeded. (2) Medical cost trends surprise to the upside, rate notice is worse than expected, and the Stars headwind creates cascading problems — $9 becomes genuinely challenging. Scenario 1 seems more likely given management's explicit language about conservatism and their FY2025 track record. The $9 guide was set knowing about the Stars loss, V28 impact, and below-trend rate notice. Management would not set a floor they didn't have high confidence in meeting. The 'at least' qualifier is designed to be beaten.
This is a high-conviction YES scenario. Management explicitly signaled conservatism, has a proven beat pattern, and used 'at least' language. Health insurers with sophisticated actuarial teams generally set guidance they can beat — it's a credibility management strategy. The $9 floor likely incorporates worst-case assumptions on multiple variables simultaneously (medical cost trend at upper end, rate notice at lower end, new member costs at upper end). The probability of ALL worst-case assumptions materializing simultaneously is low. Missing $9 would be a career-threatening miss for the CFO who just explicitly called the guidance conservative.
The conservative guidance signal is strong but the environment is genuinely challenging. The $3.5B Stars headwind is the largest single-year revenue reduction in Humana's history. Unlike FY2025 where management was navigating a relatively known environment, FY2026 involves unprecedented membership growth (25%), an unprecedented Stars loss, and potentially below-trend CMS rates. These are not normal operating conditions for conservative guidance — they're transformation conditions where actual outcomes could diverge materially from models. The FY2025 analogy is imperfect because the scale of change in FY2026 is much larger. Still, probability above coin-flip given explicit conservatism signals.
Management's language choices are telling: 'at least $9,' 'higher than typical conservatism,' 'broad haircut.' These are not standard guidance language — they're deliberately signaling to the market that $9 is a floor with upside. CFOs do not use this language unless they have high internal confidence that the floor will be exceeded. The question is the magnitude of the beat, not whether it happens. The main risk is a black swan (pandemic, major regulatory change, unexpected litigation) that invalidates all actuarial modeling. Absent external shocks, $9 appears very beatable.
Management explicitly called guidance conservative with a broad haircut. FY2025 was beaten despite $550M+ in incremental investments. 'At least $9' signals a floor. Very high probability of beat absent external shock.
Conservative guidance is a strong signal, but 2026 is genuinely unprecedented territory with the Stars headwind and 25% growth. The actuarial uncertainty is much higher than FY2025. Still, management set the floor knowing about all these challenges, and the 'broad haircut' suggests meaningful buffer. Probability above coin-flip but not as high as FY2025 beat would suggest.
The combination of explicit conservatism language, historical beat pattern, and 'at least' qualifier creates a strong base case for exceeding $9. The $3.5B headwind is the key risk but is a known quantity that was factored into guidance. Medical cost surprises or rate notice worse than expected could narrow the buffer but are unlikely to eliminate it entirely. Good probability of YES.
Resolution Criteria
Resolves YES if Humana's reported FY2026 adjusted diluted EPS exceeds $9.00 as disclosed in the FY2026 earnings press release or 10-K. Resolves NO if adjusted diluted EPS is $9.00 or below.
Resolution Source
Humana FY2026 earnings press release or 10-K filing
Source Trigger
Conservative guidance may contain upside — CFO stated 'higher than typical conservatism' including a 'broad haircut' on assumptions
Full multi-lens equity analysis